ConductScience.org, home

Paper24252773

Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm.

Garcia-Olivé I and 9 others. J Vasc Interv Radiol, 2014. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm. Papers, record 24252773. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24252773

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm.
PubMed
Journal
J Vasc Interv Radiol
PubMed
Year
2014
PubMed
Publication types
Journal Article, Observational Study
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
1.98
iCite
Revised in PubMed
2016-11-25
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Garcia-Olivé IIgnasi
2Sanz-Santos JJose
3Centeno CCarmen
4Andreo FFelipe
5Muñoz-Ferrer AAida
6Serra PPere
7Sampere JJaume
8Michavila JMJosep Maria
9Muchart JJordi
10Manzano JRJuan Ruiz

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bronchial ArteriesMajor topic
Embolization, TherapeuticMajor topic
HemoptysisMajor topic
Lung NeoplasmsMajor topic
Aged
Disease Progression
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Radiography
Recurrence
Retrospective Studies
Risk Factors
Time Factors
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
42170297International Consensus on Severe Lung Cancer-The Second Edition.Transl Lung Cancer Res2026https://conductscience.org/library/papers/42170297PubMed
40936993Risk factors of hemoptysis recurrence after bronchial artery embolization and patient feedbacks.Turk Gogus Kalp Damar Cerrahisi Derg2025https://conductscience.org/library/papers/40936993PubMed
40735168Bronchial artery embolization for haemoptysis in patients with lymphoma and leukaemia.BJR Case Rep2025https://conductscience.org/library/papers/40735168PubMed
40113741Severe hemoptysis associated with lung cancer in the ICU: recurrence and outcome.Ann Intensive Care2025https://conductscience.org/library/papers/40113741PubMed
39423778Non-emergent hemoptysis in patients with primary or metastatic lung tumors: The role of transarterial embolization.Eur J Radiol2024https://conductscience.org/library/papers/39423778PubMed
38003912Pulmonary Artery Embolization in the Management of Hemoptysis Related to Lung Tumors.J Pers Med2023https://conductscience.org/library/papers/38003912PubMed
37835458Hemoptysis in Cancer Patients.Cancers (Basel)2023https://conductscience.org/library/papers/37835458PubMed
37311841Endovascular Management of Life-Threatening Hemoptysis in Primary Lung Cancer: A Retrospective Study.Cardiovasc Intervent Radiol2023https://conductscience.org/library/papers/37311841PubMed
36591505Case Report: Bronchial artery embolization and chemoradiotherapy for central squamous cell lung carcinoma with rapid regression.Front Oncol2022https://conductscience.org/library/papers/36591505PubMed
36127690Comparison of n-butyl-2-cyanoacrylate and polyvinyl alcohol particles for bronchial artery embolisation in primary lung cancer: a retrospective cohort study.Respir Res2022https://conductscience.org/library/papers/36127690PubMed
36062230Advancements in Interventional Oncology of the Chest: Transarterial Chemoembolization and Related Therapies.Semin Intervent Radiol2022https://conductscience.org/library/papers/36062230PubMed
35484185Bronchial artery embolization for hemoptysis caused by metastatic hepatocellular carcinoma.Sci Rep2022https://conductscience.org/library/papers/35484185PubMed
34362373Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis.Respir Res2021https://conductscience.org/library/papers/34362373PubMed
33855367Transarterial management of advance lung cancer.Jpn J Clin Oncol2021https://conductscience.org/library/papers/33855367PubMed
31435125Embolization of Chest Neoplasms: The Next Frontier in Interventional Oncology?Semin Intervent Radiol2019https://conductscience.org/library/papers/31435125PubMed
31123382Anterior Cord Syndrome after Embolization for Malignant Hemoptysis.Semin Intervent Radiol2019https://conductscience.org/library/papers/31123382PubMed
29249863Palliative Embolization for Refractory Bleeding.Semin Intervent Radiol2017https://conductscience.org/library/papers/29249863PubMed
28942519An applied anatomical study of bronchial artery.Surg Radiol Anat2018https://conductscience.org/library/papers/28942519PubMed
28608003Transarterial chemoembolization for management of hemoptysis: initial experience in advanced primary lung cancer patients.Jpn J Radiol2017https://conductscience.org/library/papers/28608003PubMed
26380767Bronchial artery embolization for malignant hemoptysis: a single institutional experience.J Thorac Dis2015https://conductscience.org/library/papers/26380767PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24252773

GET https://conductscience.org/api/papers/v1/24252773/authors